Investor relations

Listed on NASDAQ since 1991 and a member of the S&P 500®, IDEXX Laboratories, Inc. (IDXX) is the global leader in veterinary diagnostics, software, and water microbiology testing.

Listen: Investor Day

IDXX $388.60*
0.00 (0.00%)

Press releases & news

Product, financial, and organizational news

SEC filings

Quarterly, yearly, and other SEC filings

Events & presentations

Upcoming events, past events and presentations

Company overview

Corporate governance, corporate responsibility, and annual reports

Q2 2022 Results - August 2

Press Release
Snapshot

Webcast

10-Q

Corporate Responsibility Report

Corporate Responsibility is fundamental to how IDEXX operates as a business, employer, supplier, customer, and member of the community.

Read our 2021 report

Investor resources

Latest earnings

Q2 2022

Q2 2022 Earnings Snapshot

Earnings release archive

Request materials

Request email materials

Request printed materials

Investor resources and FAQs

Upcoming earnings dates

Q3 2022: November 1

Investor resources

Investor Relations
One IDEXX Drive
Westbrook, Maine 04092

1-207-556-8155 or 1-800-548-6733
Fax: 1-207-556-4427
Email

Latest news

IDEXX Announces Second Quarter Results

IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive Care and Critical Cases

IDEXX to Present at Stifel Conference and IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day

IDEXX Announces First Quarter Results

IDEXX to Present at Two Upcoming Institutional Investor Conferences

IDEXX Announces Fourth Quarter and Full Year 2021 Results

IDEXX Innovative Diagnostic and Software Solutions Provide Workflow Efficiency and Faster, More Confident Clinical Decisions

IDEXX Enables Improved Cancer Diagnosis and Personalized Care through Expanded Oncology Offering

IDEXX Announces Third Quarter Results

IDEXX Acquires ezyVet

IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative

IDEXX Elects Dr. Asha S. Collins to Board of Directors

IDEXX Provides U.S. Companion Animal Market Trends Update
View the U.S. Companion Animal Market Trends Snapshot

IDEXX Launches Groundbreaking New ProCyte One Hematology Analyzer with Dramatically Simplified User Experience

IDEXX Expands ImageVue Digital Imaging Portfolio, Making Enhanced Radiation Safety and Superior Diagnostic Image Quality Affordable to More Veterinarians

OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

IDEXX Provides U.S. Companion Animal Market Trends Update View the U.S. Companion Animal Market Trends Snapshot

OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

IDEXX Makes Pet Test for COVID-19 Virus Available to Veterinarians

IDEXX Newsroom

Events and presentations

IDEXX Second Quarter 2022 Earnings Conference Call
August 2, 2022, 8:30 am EDT

IDEXX Investor Day
Thursday, August 11, 2022

Stifel Jaws & Paws Conference
Wednesday, June 1, 2022, 1:50-2:20 pm EDT

IDEXX 2022 Annual Meeting of Shareholders:  Answers to Shareholders’ Questions
View document

IDEXX First Quarter 2022 Earnings Conference Call
Wednesday, May 4, 2022, 8:30 am EDT

43rd Annual Raymond James Institutional Investors Conference
Monday, March 7, 2022, 11:00 am EST
View presentation

IDEXX Fourth Quarter 2021 Earnings Conference Call
Wednesday, February 2, 2022, 8:30 am EST

IDEXX Third Quarter 2021 Earnings Conference Call
Tuesday, November 2, 2021, 8:30 am EDT

IDEXX Virtual Investor Day
Thursday, August 12, 2021, 10:00 am EDT
View presentation

IDEXX Second Quarter 2021 Earnings Conference Call
Friday, July 30, 2021, 8:30 am EDT

View all events and presentations

*Pricing delayed by 20 minutes